IBDEI0LV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9711,1,3,0)
 ;;=3^Ureterolithiasis
 ;;^UTILITY(U,$J,358.3,9711,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,9711,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,9712,0)
 ;;=I95.9^^72^651^1
 ;;^UTILITY(U,$J,358.3,9712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9712,1,3,0)
 ;;=3^Hypotension
 ;;^UTILITY(U,$J,358.3,9712,1,4,0)
 ;;=4^I95.9
 ;;^UTILITY(U,$J,358.3,9712,2)
 ;;=^5008080
 ;;^UTILITY(U,$J,358.3,9713,0)
 ;;=I95.1^^72^651^2
 ;;^UTILITY(U,$J,358.3,9713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9713,1,3,0)
 ;;=3^Orthostatic Hypotension
 ;;^UTILITY(U,$J,358.3,9713,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,9713,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,9714,0)
 ;;=D64.9^^72^651^3
 ;;^UTILITY(U,$J,358.3,9714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9714,1,3,0)
 ;;=3^Anemia
 ;;^UTILITY(U,$J,358.3,9714,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,9714,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,9715,0)
 ;;=R79.1^^72^651^4
 ;;^UTILITY(U,$J,358.3,9715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9715,1,3,0)
 ;;=3^Abnormal Coagulation Profile (Elevated INR)
 ;;^UTILITY(U,$J,358.3,9715,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,9715,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,9716,0)
 ;;=D70.9^^72^651^5
 ;;^UTILITY(U,$J,358.3,9716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9716,1,3,0)
 ;;=3^Neutropenia
 ;;^UTILITY(U,$J,358.3,9716,1,4,0)
 ;;=4^D70.9
 ;;^UTILITY(U,$J,358.3,9716,2)
 ;;=^334186
 ;;^UTILITY(U,$J,358.3,9717,0)
 ;;=D69.6^^72^651^6
 ;;^UTILITY(U,$J,358.3,9717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9717,1,3,0)
 ;;=3^Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,9717,1,4,0)
 ;;=4^D69.6
 ;;^UTILITY(U,$J,358.3,9717,2)
 ;;=^5002370
 ;;^UTILITY(U,$J,358.3,9718,0)
 ;;=D61.818^^72^651^7
 ;;^UTILITY(U,$J,358.3,9718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9718,1,3,0)
 ;;=3^Pancytopenia
 ;;^UTILITY(U,$J,358.3,9718,1,4,0)
 ;;=4^D61.818
 ;;^UTILITY(U,$J,358.3,9718,2)
 ;;=^340501
 ;;^UTILITY(U,$J,358.3,9719,0)
 ;;=C94.6^^72^651^8
 ;;^UTILITY(U,$J,358.3,9719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9719,1,3,0)
 ;;=3^Myelodysplastic Disease
 ;;^UTILITY(U,$J,358.3,9719,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,9719,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,9720,0)
 ;;=C90.00^^72^651^9
 ;;^UTILITY(U,$J,358.3,9720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9720,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,9720,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,9720,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,9721,0)
 ;;=C95.10^^72^651^10
 ;;^UTILITY(U,$J,358.3,9721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9721,1,3,0)
 ;;=3^Chronic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,9721,1,4,0)
 ;;=4^C95.10
 ;;^UTILITY(U,$J,358.3,9721,2)
 ;;=^5001853
 ;;^UTILITY(U,$J,358.3,9722,0)
 ;;=L04.0^^72^651^11
 ;;^UTILITY(U,$J,358.3,9722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9722,1,3,0)
 ;;=3^Acute Lymphadenitis,Face/Head/Neck
 ;;^UTILITY(U,$J,358.3,9722,1,4,0)
 ;;=4^L04.0
 ;;^UTILITY(U,$J,358.3,9722,2)
 ;;=^5009069
 ;;^UTILITY(U,$J,358.3,9723,0)
 ;;=R22.1^^72^651^12
 ;;^UTILITY(U,$J,358.3,9723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9723,1,3,0)
 ;;=3^Localized Swelling/Mass/Lump,Neck
 ;;^UTILITY(U,$J,358.3,9723,1,4,0)
 ;;=4^R22.1
 ;;^UTILITY(U,$J,358.3,9723,2)
 ;;=^5019285
 ;;^UTILITY(U,$J,358.3,9724,0)
 ;;=I89.0^^72^651^13
 ;;^UTILITY(U,$J,358.3,9724,1,0)
 ;;=^358.31IA^4^2
